🔴 Relay Therapeutics is trading 4.23% down in pre-market — catalyst unclear

Relay Therapeutics is trading at $17.22, down 4.23% in pre-market; the reason for the decline remains unclear.

• Searches found no clear company-specific announcement on October 13 explaining the decline; the company’s press-release page showed no October 13 announcement in the results reviewed.
• Available coverage noted a Bank of America Buy-rating reiteration, not a negative catalyst.
• Major indices were mixed, and their supplied moves do not establish a clear broad-market explanation.